Clinical Trial Update: Comparison of Efficacy and Safety Between Imidafenacin and Fesoterodine in Patients With Overactive Bladder [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial comparing the efficacy and safety of imidafenacin versus fesoterodine in adults with overactive bladder.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Overactive Bladder

Drugs mentioned

• Fesoterodine (Toviaz) (fesoterodine)
• Imidafenacin (Imidafenacin)

Snippet

Sponsor: LG Life Sciences | Conditions: Overactive Bladder | Phase 4 | Status: COMPLETED